News
Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to ...
University of Queensland (UQ) researchers have become the first in the world to successfully grow fully functioning human ...
The new exhibit is available at the North End Event Center, and includes all kinds of space-oriented attractions.
6d
PCMag UK on MSNSam Altman Wants His Own Neuralink, But Are You Ready to Merge Your Brain With ChatGPT?
OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink.
2d
ExtremeTech on MSNGene Therapy Could Let Future Implants Control the Brain Via Ultrasound
One of Sam Altman’s pet projects aims to engineer the brain to better work with brain-computer interface implants.
Laurus Labs (LAURUSLABS.NS) announced a Composite Scheme of Arrangement, subject to regulatory approvals, following a Board meeting on August 21, 2025. The plan, approved under Se ...
Hyderabad: In a restructuring exercise, Laurus Labs is demerging Unit-1, which is the API manufacturing component of its ...
Whether the acquisition of Core Scientific by CoreWeave goes ahead will provide a signal on investor confidence in the technology ...
Aptorum Group Limited (NASDAQ: APM) shares dropped 33.18% in Friday's pre-market trading after soaring 234.65% the previous session, driven by DiamiR's test approval and merger news, with trading ...
A Pasadena startup is looking to capitalize on the AI boom by investing in the infrastructure that powers data centers - the ...
Aptorum stock rises after DiamiR Biosciences secures New York approval for its APOE Genotyping test ahead of a planned merger.
Sam Altman’s Merge Labs has entered the race to rival companies like Neuralink in the development of brain-computer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results